Alandsbanken Abp A (ALBAV)
Nasdaq Helsinki · Finland · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 43.00 |
|---|---|
| 52-week range | 40.70 – 59.20 |
| Return, 1 month / 3 months | −4.4% / −6.5% |
| Return, 1 year / 3 years | −4.2% / +60.3% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 25.4% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 8.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Alandsbanken Abp, known in English as the Bank of Aland, is a Finnish commercial bank based in Mariehamn on the Aland Islands. It serves private individuals, companies and institutional clients, with particular emphasis on private banking and wealth management alongside ordinary banking services such as deposits, lending and payment handling. The bank also provides asset management and IT services, and it operates branches in mainland Finland and in Sweden, giving it a Nordic customer base.
The shares are listed on the Nasdaq Helsinki in Finland under the code ALBAV, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Alandsbanken Abp A (ALBAV) trades on the Nasdaq Helsinki in Finland. It last closed at EUR 43.00 on 27 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 102 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.2% and over the last three months it fell 6.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Nasdaq Helsinki
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.1% | ||
| From 52-week high | -25.6% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.5% | ||
| 6-month return | -10.8% | ||
| 12-month return, skipping the last month | 0.2% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 25.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 76 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 8.1% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | −4.4% |
| 3 months | −6.5% |
| 6 months | −10.8% |
| 1 year | −4.2% |
| 3 years | +60.3% |
| 5 years | +68.8% |
Signals
| 50-day / 200-day average | 44.76 / 46.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.22 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Jul 2026 | EUR 0.7500 |
| 31 Mar 2026 | EUR 2.7500 |
| 26 Mar 2025 | EUR 2.4000 |
| 27 Mar 2024 | EUR 2.4000 |
| 31 Mar 2023 | EUR 1.6000 |
| 31 Mar 2022 | EUR 0.4500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Nasdaq Helsinki; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.